Zoledronic acid combined with adjuvant endocrine therapy of tamoxifen versus anastrozol plus ovarian function suppression in premenopausal early breast cancer: final analysis of the Austrian Breast and Colorectal Cancer Study Group Trial 12
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Zoledronic acid combined with adjuvant endocrine therapy of tamoxifen versus anastrozol plus ovarian function suppression in premenopausal early breast cancer: final analysis of the Austrian Breast and Colorectal Cancer Study Group Trial 12
Authors
Keywords
-
Journal
ANNALS OF ONCOLOGY
Volume 26, Issue 2, Pages 313-320
Publisher
Oxford University Press (OUP)
Online
2014-11-18
DOI
10.1093/annonc/mdu544
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Combined Cancer Therapy: Strategies to Overcome Acquired Aromatase Inhibitor Resistance
- (2014) Susan Kesmodel et al. CURRENT PHARMACEUTICAL DESIGN
- Adjuvant Exemestane with Ovarian Suppression in Premenopausal Breast Cancer
- (2014) Olivia Pagani et al. NEW ENGLAND JOURNAL OF MEDICINE
- St. Gallen 2013: Brief Preliminary Summary of the Consensus Discussion
- (2013) Nadia Harbeck et al. Breast Care
- German Adjuvant Intergroup Node-Positive Study: A Phase III Trial to Compare Oral Ibandronate Versus Observation in Patients With High-Risk Early Breast Cancer
- (2013) Gunter von Minckwitz et al. JOURNAL OF CLINICAL ONCOLOGY
- Zoledronic acid (zoledronate) for postmenopausal women with early breast cancer receiving adjuvant letrozole (ZO-FAST study): final 60-month results
- (2012) R. Coleman et al. ANNALS OF ONCOLOGY
- Effects of Bone-Targeted Agents on Cancer Progression and Mortality
- (2012) R. Coleman et al. JNCI-Journal of the National Cancer Institute
- Oral clodronate for adjuvant treatment of operable breast cancer (National Surgical Adjuvant Breast and Bowel Project protocol B-34): a multicentre, placebo-controlled, randomised trial
- (2012) Alexander HG Paterson et al. LANCET ONCOLOGY
- Final 5-year results of Z-FAST trial
- (2011) Adam M. Brufsky et al. CANCER
- Direct and indirect anticancer activity of bisphosphonates: A brief review of published literature
- (2011) Michael Gnant et al. CANCER TREATMENT REVIEWS
- Zoledronic acid preserves bone mineral density in premenopausal women who develop ovarian failure due to adjuvant chemotherapy: Final results from CALGB trial 79809
- (2011) C.L. Shapiro et al. EUROPEAN JOURNAL OF CANCER
- Impact of Body Mass Index on the Efficacy of Endocrine Therapy in Premenopausal Patients With Breast Cancer: An Analysis of the Prospective ABCSG-12 Trial
- (2011) Georg Pfeiler et al. JOURNAL OF CLINICAL ONCOLOGY
- Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 62-month follow-up from the ABCSG-12 randomised trial
- (2011) Michael Gnant et al. LANCET ONCOLOGY
- Breast-Cancer Adjuvant Therapy with Zoledronic Acid
- (2011) Robert E. Coleman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy of zoledronic acid in postmenopausal women with early breast cancer receiving adjuvant letrozole: 36-month results of the ZO-FAST Study
- (2010) H. Eidtmann et al. ANNALS OF ONCOLOGY
- Bone turnover across the menopause transition
- (2010) Kristy M. Nicks et al. Annals of the New York Academy of Sciences
- Bisphosphonates for osteoporosis treatment are associated with reduced breast cancer risk
- (2010) P A Newcomb et al. BRITISH JOURNAL OF CANCER
- Oral Bisphosphonate Use and Breast Cancer Incidence in Postmenopausal Women
- (2010) Rowan T. Chlebowski et al. JOURNAL OF CLINICAL ONCOLOGY
- Use of Bisphosphonates and Risk of Postmenopausal Breast Cancer
- (2010) Gad Rennert et al. JOURNAL OF CLINICAL ONCOLOGY
- Effect of zoledronic acid on disseminated tumour cells in women with locally advanced breast cancer: an open label, randomised, phase 2 trial
- (2010) Rebecca Aft et al. LANCET ONCOLOGY
- Tumor Self-Seeding by Circulating Cancer Cells
- (2009) Mi-Young Kim et al. CELL
- Endocrine Therapy plus Zoledronic Acid in Premenopausal Breast Cancer
- (2009) Michael Gnant et al. NEW ENGLAND JOURNAL OF MEDICINE
- Bisphosphonate treatment in primary breast cancer: Results from a randomised comparison of oral pamidronate versus no pamidronate in patients with primary breast cancer
- (2008) Bent Kristensen et al. ACTA ONCOLOGICA
- Exploring the anti-tumour activity of bisphosphonates in early breast cancer
- (2008) M.C. Winter et al. CANCER TREATMENT REVIEWS
- Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 5-year follow-up of the ABCSG-12 bone-mineral density substudy
- (2008) Michael Gnant et al. LANCET ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started